Alpha 2.0
Login Register
» Authors » Alma Gabriela Kosa

Alma Gabriela Kosa

Explore the profile of Alma Gabriela Kosa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 487
Followers 0
Related Specialties
Pharmacology
General Medicine
Infectious Diseases
Top 10 Co-Authors
Simin Aysel Florescu
Corneliu Petru Popescu
Albert Prats-Uribe
Jacklyn Sui
Liis Lohur
Lauren Ferguson
Dainis Krievins
Maria Cisneros
Laura Clusa Cuesta
Colm Bergin
Published In
Antibiotics (Basel)
JAMA
Vaccines (Basel)
Vaccine
Euro Surveill
Affiliations
Soon will be listed here.
Recent Articles
1.
A Possible Tool for Guiding Therapeutic Approaches to Urinary Infections with : Analyzing a Dataset from a Romanian Tertiary Hospital
Lazar D, Nica M, Codreanu D, Kosa A, Visinescu L, Popescu C, et al.
Antibiotics (Basel) . 2025 Jan; 13(12. PMID: 39766560
The emergence of carbapenem-resistant pathogenic bacteria is a growing global public health concern. Carbapenem-resistant uropathogenic strains of can cause uncomplicated or complicated urinary tract infections, leading to a high risk...
2.
Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023)
Savulescu C, Prats-Uribe A, Brolin K, Uuskula A, Bergin C, Fleming C, et al.
Vaccine . 2024 Dec; 45:126615. PMID: 39724693
Introduction: Repeated COVID-19 booster vaccination was recommended in healthcare workers (HCWs) to maintain protection. We measured the relative vaccine effectiveness (rVE) of the second booster dose of COVID-19 vaccine compared...
3.
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021-May 2023
Savulescu C, Prats-Uribe A, Brolin K, Makaric Z, Uuskula A, Panagiotakopoulos G, et al.
Vaccines (Basel) . 2024 Nov; 12(11). PMID: 39591197
European countries have included healthcare workers (HCWs) among priority groups for COVID-19 vaccination. We established a multi-country hospital network to measure the SARS-CoV-2 incidence and effectiveness of COVID-19 vaccines among...
4.
Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24
Savulescu C, Prats-Uribe A, Brolin K, Uuskula A, Bergin C, Fleming C, et al.
Euro Surveill . 2024 Nov; 29(44). PMID: 39484687
COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs...
5.
Carbapenem-Resistant NDM and OXA-48- Producing : From Menacing Superbug to a Mundane Bacteria; A Retrospective Study in a Romanian Tertiary Hospital
Lazar D, Nica M, Dascalu A, Oprisan C, Albu O, Codreanu D, et al.
Antibiotics (Basel) . 2024 May; 13(5). PMID: 38786163
Background: Carbapenem-resistant (Cr-Kpn) is becoming a growing public health problem through the failure of adequate treatment. This study's objectives are to describe the sources of Cr-Kpn in our hospital over...
6.
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Angus D, Buzgau A, Cheng A, Higgins A, Hullegie S, Lawler P, et al.
JAMA . 2020 Sep; 324(13):1317-1329. PMID: 32876697
Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, And Participants: An...